The Discounted Cash Flow (DCF) valuation of Theralase Technologies Inc (TLT.V) is (70.16) CAD. With the latest stock price at 0.21 CAD, the upside of Theralase Technologies Inc based on DCF is -33511.6%.
Based on the latest price of 0.21 CAD and our DCF valuation, Theralase Technologies Inc (TLT.V) is a sell. selling TLT.V stocks now will result in a potential gain of 33511.6%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.5% - 7.1% | 6.3% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (326.67) - (39.55) | (70.16) |
| Upside | -155656.6% - -18934.6% | -33511.6% |